Market of dermatologists prescribing for rosacea and acne is very focused, so Foamix says it can manage commercialization of topical minocycline foam on its own.
Buoyed By Phase III Rosacea Success, Foamix Plans Commercial Transition
By Michael Tattory|
2018-11-08T15:46:52-04:00
November 7th, 2018|News|Comments Off on Buoyed By Phase III Rosacea Success, Foamix Plans Commercial Transition